HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daxin Peng Selected Research

sialic acid receptor

1/2017The T160A hemagglutinin substitution affects not only receptor binding property but also transmissibility of H5N1 clade 2.3.4 avian influenza virus in guinea pigs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daxin Peng Research Topics

Disease

40Influenza in Birds (Avian Flu)
12/2022 - 06/2002
16Infections
01/2022 - 07/2005
7Human Influenza (Influenza)
01/2022 - 11/2010
4Virus Diseases (Viral Diseases)
01/2021 - 08/2015
3Bacterial Infections (Bacterial Infection)
12/2021 - 07/2005
2Inflammation (Inflammations)
07/2020 - 11/2017
1Communicable Diseases (Infectious Diseases)
10/2020
1Rheumatoid Arthritis
01/2020
1Body Weight (Weight, Body)
01/2020
1Acute Lung Injury
04/2017
1Acute-Phase Reaction
04/2017
1Lung Injury
04/2017
1Brucellosis (Malta Fever)
09/2014
1Shock
07/2014
1Respiratory Tract Infections (Respiratory Tract Infection)
06/2011
1Otitis Media
06/2011

Drug/Important Bio-Agent (IBA)

19VaccinesIBA
12/2022 - 11/2010
15Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2012
12Hemagglutinins (Hemagglutinin)IBA
01/2022 - 06/2002
9Biological ProductsIBA
03/2022 - 12/2009
7Neuraminidase (Sialidase)IBA
10/2021 - 10/2008
3Inactivated VaccinesIBA
11/2021 - 01/2019
3EpitopesIBA
10/2021 - 03/2013
3Amino AcidsFDA Link
01/2020 - 06/2002
2Peptides (Polypeptides)IBA
12/2022 - 10/2021
2Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2021
2Tigecycline (Tygacil)FDA Link
12/2021 - 10/2021
2Antiviral Agents (Antivirals)IBA
09/2020 - 01/2020
2Attenuated VaccinesIBA
01/2020 - 01/2017
2Virulence Factors (Pathogenicity Factors)IBA
11/2005 - 07/2005
1OccludinIBA
01/2022
1Colistin (Coly-Mycin)FDA Link
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2022
1Long Noncoding RNAIBA
12/2021
1RNA (Ribonucleic Acid)IBA
12/2021
1Carbapenems (Carbapenem Antibiotics)IBA
12/2021
1Riboflavin (Vitamin B2)FDA LinkGeneric
11/2021
1Marker VaccinesIBA
10/2021
1N-Acetylneuraminic Acid (Sialic Acid)IBA
03/2021
1CytokinesIBA
12/2020
1Suppressor of Cytokine Signaling 1 ProteinIBA
12/2020
1Methionine (L-Methionine)FDA Link
11/2020
1DNA (Deoxyribonucleic Acid)IBA
10/2020
1ferric oxide (iron oxide)IBA
09/2020
1ChitosanIBA
09/2020
1Immunoglobulin A (IgA)IBA
09/2020
1Inositol (Myoinositol)IBA
07/2020
1EnzymesIBA
07/2020
1teriflunomideIBA
01/2020
1Janus KinasesIBA
01/2020
1Janus Kinase InhibitorsIBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1Leflunomide (Arava)FDA LinkGeneric
01/2020
1SuspensionsIBA
03/2019
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
01/2019
1LipidsIBA
01/2019
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2018
1NF-kappa B (NF-kB)IBA
11/2017
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2017
1Complement System Proteins (Complement)IBA
04/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2017
1Influenza Vaccines (Influenza Vaccine)FDA Link
01/2017
1sialic acid receptorIBA
01/2017
1Type III Secretion SystemsIBA
01/2016
1EmulsionsIBA
01/2016
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
01/2016
1AntigensIBA
08/2015
1LigandsIBA
08/2015
1FlagellinIBA
08/2015
1Subunit VaccinesIBA
08/2015
1AcidsIBA
07/2014
1Glycoproteins (Glycoprotein)IBA
01/2014
1Interleukin-6 (Interleukin 6)IBA
09/2012
1Immunoglobulins (Immunoglobulin)IBA
12/2011
1Immunoglobulin G (IgG)IBA
11/2010
1MF59 oil emulsionIBA
11/2010
1Secretory Immunoglobulin A (SIgA)IBA
11/2010
1OligosaccharidesIBA
07/2005
1Basic Amino Acids (Basic Amino Acid)IBA
06/2002

Therapy/Procedure

1Intranasal Administration
11/2010